Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
25%
Ph not_applicable
3
75%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Other(1)

Detailed Status

Active, not recruiting2
Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

active_not_recruiting250%
completed125%
unknown125%

Recent Activity

2 active trials
Showing 4 of 4
completedphase_1

NASA Prebreathe Study

NCT06740305
active_not_recruitingnot_applicable

Identifying Biological Markers for Altitude Exposure and Use of Recombinant Human Erythropoietin (rHuEPO)

NCT04227665
active_not_recruitingnot_applicable

Effect of Rehabilitation on the Respiratory Signal in Patients With COPD and Exercise-Induced Desaturation

NCT07107828
unknownnot_applicable

Human Adaptation to High Altitude

NCT01627652

Clinical Trials (4)

Showing 4 of 4 trials
NCT06740305Phase 1

NASA Prebreathe Study

Completed
NCT04227665Not Applicable

Identifying Biological Markers for Altitude Exposure and Use of Recombinant Human Erythropoietin (rHuEPO)

Active Not Recruiting
NCT07107828Not Applicable

Effect of Rehabilitation on the Respiratory Signal in Patients With COPD and Exercise-Induced Desaturation

Active Not Recruiting
NCT01627652Not Applicable

Human Adaptation to High Altitude

Unknown

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4